J Lipid Res 2013,
PMID: 23319743
Liu, Hailan; Wu, Xi; Dong, Zizheng; Luo, Zhiyong; Zhao, Zhenwen; Xu, Yan; Zhang, Jian-Ting
Fatty acid synthase (FASN) is a key enzyme in the synthesis of palmitate, the precursor of major nutritional, energetic, and signaling lipids. FASN expression is upregulated in many human cancers and appears to be important for cancer cell survival. Overexpression of FASN has also been found to associate with poor prognosis and higher risk of recurrence of human cancers. Indeed, elevated FASN expression has been shown to contribute to drug resistance. However, the mechanism of FASN-mediated drug resistance is currently unknown. In this study, we show that FASN overexpression causes resistance to multiple anticancer drugs via inhibiting drug-induced ceramide production, caspase 8 activation, and apoptosis. We also show that FASN overexpression suppresses tumor necrosis factor-α production and nuclear factor-κB activation as well as drug-induced activation of neutral sphingomyelinase. Thus, TNF-α may play an important role in mediating FASN function in drug resistance.
Document information provided by NCBI PubMed
Text Mining Data
neutral sphingomyelinase ⊣ FASN: "
We also show that
FASN overexpression
suppresses tumor necrosis factor-a production and nuclear factor-?B activation as well as drug induced activation of
neutral sphingomyelinase
"
tumor necrosis factor-a ⊣ FASN: "
We also show that FASN overexpression suppresses tumor necrosis factor-a production and nuclear factor-?B activation as well as drug induced activation of neutral sphingomyelinase
"
tumor necrosis factor-a → neutral sphingomyelinase: "
We also show that FASN overexpression suppresses tumor necrosis factor-a production and nuclear factor-?B activation as well as drug induced activation of neutral sphingomyelinase
"
Manually curated Databases
No curated data.